Веселовская Н.Г., Чумакова Г.А., Шенкова Н.Н., Осипова Е.С., Гриценко О.В. Модель прогнозирования риска коронарного атеросклероза у пациентов с висцеральным ожирением. Рос. кардиол. журн. 2015; 20 (4): 49–54.
Veselovskaya N.G., Chumakova G.A., Shenkova N.N., Osipova E.S., Gritsenko O.V. Model for predicting of the risk of coronary atherosclerosis in patients with visceral obesity. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2015; 20 (4): 49–54. [In Russian].
2. Воробьева Е.Н., Воробьев Р.И., Шарлаева Е.А., Фомичева М.Л., Соколова Г.Г., Казызаева А.С., Батанина И.А. Сагиттальный диаметр как маркер коронарного риска. Acta Biol. Sib. 2015; 1 (1-2): 38–50.
Vorobyeva E.N., Vorobyev R.I., Sharlayeva E.A., Fomicheva M.L., Sokolova G.G., Kazyzayeva A.S., Batanina I.A. Sagittal diameter as a coronary risk marker. Acta Biol. Sib. 2015; 1 (1-2): 38–50. [In Russian].
3. Воробьева Е.Н., Осипова И.В., Веселовская П.Г., Мордвинова П.П., Воробьев Р.И. Методы диагностики абдоминального ожирения в клинической практике. Кардиоваскуляр. терапия и профилактика. 2006; 5 (8): 74–78.
Vorobyeva E.N., Osipova I.V., Veselovskaya N.G., Mordvinova N.I., Vorobyev R.I. Abdominal obesity diagnostics in clinical practice. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2006; 5 (8): 74–78. [In Russian].
4. Драпкина О.М., Корнеева О.Н., Ивашкин В.Т. Способ диагностики инсулинорезистентности. Пат. 2553943 РФ; Опубл. 27.05.2014.
Drapkina O.M., Korneyeva O.N., Ivashkin V.T. Method for the diagnosis of insulin resistance. Patent 2553943 RF; Published 27.05.2014. [In Russian].
5. Драпкина О.М., Шепель Р.Н., Деева Т.А. Толщина эпикардиального жира – «визитная карточка» метаболического синдрома. Ожирение и метаболизм. 2018; 15 (2): 29–34.
Drapkina O.M., Shepel R.N., Deyeva T.A. Thickness of epikardialny fat – «business card» of a metabolic syndrome. Ozhireniye i metabolism = Obesity and Metabolism. 2018; 15 (2): 29–34. [In Russian].
6. Дружилов М.А., Кузнецова Т.Ю. Толщина эпикардиального жира как инструмент прогнозирования неосложненного ожирения. Journal of Biomedical Technologies. 2015; 2: 49–58.
Druzhilov M.A., Kuznetsova T.Yu. Epicardial fat thickness as a tool for predicting uncomplicated obesity. Journal of Biomedical Technologies. 2015; (2): 49–58. [In Russian].
7. Кологривова И.В., Винницкая И.В., Кошельская О.А., Суслова Т.Е. Висцеральное ожирение и кардиометаболический риск: особенности гормональной и иммунной регуляции. Ожирение и метаболизм. 2017; 14 (3): 3–10.
Kologrivova I.V., Vinnitskaya I.V., Koshelskaya O.A., Suslova T.E. Visceral obesity and cardiometabolic risk: features of hormonal and immune regulation. Ozhireniye i metabolism = Obesity and Metabolism. 2017; 14 (3): 3–10. [In Russian].
8. Лутов Ю.В., Васильева О.В., Новикова Е.Г., Селятицкая В.Г. Взаимосвязь метаболического синдрома и его компонентов с инсулинорезистентностью и дисфункцией висцеральной жировой ткани у мужчин. Соврем. пробл. науки и образования. 2017; (3): 48.
Lutov Yu.V., Vasilyeva O.V., Novikova E.G., Selyatitskaya V.G. The relationship of metabolic syndrome and its components with insulin resistance and dysfunction of visceral adipose tissue in men. Sovremennyye problemy nauki i obrazovaniya = Modern Problems of Science and Education. 2017; (3): 48. [In Russian].
9. Методы исследования нутритивного статуса у детей и подростков: учебное пособие. Ред. В.П. Новикова, В.В. Юрьев. СПб.: СпецЛит, 2014. 143 c.
Research methods of nutritional status in children and teenagers: manual. Eds. V.P. Novikova, V.V. Yuryev. Saint-Petersburg: SpetsLit, 2014. 143 p. [In Russian].
10. Ожирение (клинические очерки). Ред. А.Ю. Барановский, Н.В. Ворохобина. СПб.: Невский Диалект, 2007. 240 с.
Obesity (clinical essays). Eds. A.Yu. Baranovskiy, N.V. Vorokhobina. Saint-Petersburg: Nevsky Dialect, 2007. 240 p. [In Russian].
11. Ожирение: этиология, патогенез, клинические аспекты. Ред. И.И. Дедов, Г.А. Мельниченко. М.: Медицинское информационное агентство, 2006. 456 с.
Obesity: etiology, pathogenesis, clinical aspects Eds. I.I. Dedov, G.A. Melnichenko. Moscow: Meditsinskoye informatsionnoye agentstvo, 2006. 456 p. [In Russian].
12. Сумин А.Н., Безденежных Н.А., Федорова Н.В., Безденежных А.В., Индукаева Е.В., Артамонова Г.В. Взаимосвязь висцерального ожирения и сердечно-лодыжечного сосудистого индекса с нарушениями углеводного обмена по данным исследования ЭССЕ – РФ в регионе Западной Сибири. Клин. медицина. 2018; 96 (2): 137–146.
Sumin A.N., Bezdenezhnykh N.A., Fedorova N.V., Bezdenezhnykh A.V., Indukayeva E.V., Artamonova G.V. Interrelation of visceral obesity and cardiovascular vascular index with impaired carbohydrate metabolism according to the ESSE-RF study in the region of Western Siberia. Klinicheskaya meditsina = Clinical Medicine. 2018; 96 (2): 137–146. [In Russian].
13. Чумакова Г.А., Веселовская Н.Г., Гриценко О.В., Козаренко А.А., Субботин Е.А. Эпикардиальное ожирение как фактор риска коронарного атеросклероза. Кардиология. 2013; 53 (1): 51–55.
Chumakova G.A., Veselovskaya N.G., Gritsenko O.V., Kozarenko A.A., Subbotin E.A. Epicardial obesity as a risk factor for coronary atherosclerosis. Kardiologiya = Cardiology. 2013; 53 (1): 51–55. [In Russian].
14. Шляхто Е.В., Недогода С.В., Конради А.О., Баранова Е.И., Фомин В.В., Верткин А.Л., Чумакова Г.А. Концепция новых национальных клинических рекомендаций по ожирению. Рос. кардиол. журн. 2016; (4): 7–13.
Shlyakhto E.V., Nedogoda S.V., Konradi A.O., Baranova E.I., Fomin V.V., Vertkin A.L., Chumakova G.A. The concept of novel national clinical guidelines on obesity. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2016; (4): 7–13. [In Russian].
15. Abraham T.M., Pedley A., Massaro J.M., Hoffmann U., Fox C.S. Association between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors. Circulation. 2015; 132 (17): 1639–1647.
16. Alberti K.G.M.M., Eckel R.H., Grundy S.M., Zimmet Р.Z., Cleeman J.I., Donato K.A., Fruchart J.-Ch., James W.Ph.T., Loria C.M., Smith S.C. International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint Interim statement of the International Diabetes Federation taskforce on epidemiology and prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120: 1640–1645.
17. Amato M.C., Giordano C., Galia M., Criscimanna A., Vitabile S., Midiri M., Galluzzo A. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010; 33 (4): 920–922.
18. Hsieh S.D., Ashwell M. Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int. J. Food Sci. Nutr. 2005; 56 (5): 303–307.
19. Jeong J.W., Jeong M.H., Yun K.H., Oh S.K., Park E.M., Kim Y.K., Rhee S.J., Lee E.M., Lee J., Yoo N.J., Kim N.H., Park J.C. Echocardiographic epicardial fat thickness and coronary artery disease. Circ. J. 2007; 71: 536–539.
20. Kang J., Kim Y.C., Park J.J., Kim S., Kang S.H., Cho Y.J., Yoon Y.E., Oh I.Y., Yoon C.H., Suh J.W., Cho Y.S., Youn T.J., Chae I.H., Choi D.J. Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins. Cardiovasc. Diabetol. 2018; 17 (1): 10.
21. Karastergiou K., Evans I., Ogston N., Miheisi N., Nair D., Kaski J.C., Jahangiri M., Mohamed-Ali V. Epicardial adipokines in obesity and coronary artery disease induce atherogenic changes in monocytes and endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2010; 30: 1340–1346.
22. Klein S., Allison D.B., Heymsfield S.B., Kelley D.E., Leibel R.L., Nonas C., Kahn R. Waist Circumference and Cardiometabolic Risk: a Consensus Statement from Shaping America’s Health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Obesity (Silver Spring). 2007; 15 (5): 1061–1067.
23. Natale F., Tedesco M.A., Mocerino R., de Simone V., di Marco G.M., Aronne L., Credendino M., Siniscalchi C., Calabrò P., Cotrufo M., Calabrò R. Visceral adiposity and arterial stiffness: echocardiographic epicardial fat thickness reflects, better than waist circumference, carotid arterial stiffness in a large population of hypertensives. Eur. J. Echocardiography. 2009; 10 (4): 549–555.
24. Nishio S., Kusunose K., Yamada H., Hirata Y., Ise T., Yamaguchi K., Yagi S., Soeki T., Wakatsuki T., Shimabukuro M., Sata M. Echocardiographic epicardial adipose tissue thickness is associated with symptomatic coronary vasospasm during provocative testing. J. Am. Soc. Echocardiography. 2017; 30 (10): 1021–1027.
25. Pescatori L.C, Savarino E., Mauri G., Silvestri E., Cariati M., Sardanelli F., Sconfienza L.M. Quantification of visceral adipose tissue by computed tomography and magnetic resonance imaging: reproducibility and accuracy. Radiol. Bras. 2019; 52 (1): 1–6.
26. Pinkhasov B.B., Selyatitskaya V.G., Karapetyan A.R., Astrakhantseva E.L. Metabolic syndrome in men and women with upper or lower types of body fat distribution. Health. 2012; 4 (12A): 1381–1389.
27. Eiras S., Teijeira-Fernández E., Shamagian L.G., Fernandez A.L., Vazquez-Boquete A., Gonzalez-Juanatey J.R. Extension of coronary artery disease is associated with increased IL-6 and decreased adiponectin gene expression in epicardial adipose tissue. Cytokine. 2008. 174–180.
28. Waist circumference and waist–hip ratio: report of a WHO expert consultation, Geneva, 8–11 December 2008. www.who.int/nutrition/publications/obesity/WHO_report_waistcircumference_and_waisthip_ratio/en/